Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 841–900 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…estricted eating Mediterranean diet (eTRE-MD) intervention with naltrexone/bupropion (N/B) treatment on liver fibrosis, measured as liver stiffness …
… microscopy was employed to validate molecular findings.Results REGN668 inhibits patient-specific processes in malignant lymphocytes; h…
…rotein Convertase Subtilisin/Kexin type 9 (PCSK9) inhibitors or bempedoic acid. Recent studies suggest that N=1-interventions may help disting…
…, only high levels of N-terminal pro-brain Natriuretic Peptide (NT-proBNP) provided convincing evidence of stroke risk. Previous stroke/T…
…ospital setting. MOUD will include buprenorphine, methadone and naltrexone. Experimental and observational studies will be included for re…
…, absolute neutropenia with thrombocytosis following 7 weeks of azathioprine therapy. Consequently, azathioprine was discontinued, resulted …
…ere referred to interventional cardiology (figure 1).Conclusion Rubidium-82 PET identifies an important CMD cohort, but downstream care needs i…
…n-fatal MIs occurred; 1 fatal MI, 1 fatal intracranial bleed on aspirin, 4 non-cardiac/undocumented deaths. Figures below illustrate an…
…ment and on-treatment biopsies may inform treatment outcomes to pembrolizumab.Methods We evaluated 256 baseline and 248 on-treatment biopsies…
…racic Society recommends long-term supplemental oxygen therapy (O 2) for individuals with interstitial lung disease who experience …
…Point-of-care-ultrasound (POCUS) has expanded into paediatrics in recent years, helping users t…
…, liver cancer due to HepB (AAPC 3.17), and liver cancer due to HepC (AAPC 3.14). In regard to the ASDR, a statistically significant…